Is there a role for estrogen in the prevention and treatment of urinary incontinence?

Holroyd-Leduc, Jayna M.; Straus, Sharon E.
April 2005
CMAJ: Canadian Medical Association Journal;4/12/2005, Vol. 172 Issue 8, p1003
Academic Journal
Deals with a study which aimed to determine the role of estrogen in the treatment of urinary incontinence. Subject used in the study; Result and commentary.


Related Articles

  • Hormone Therapy for Postmenopausal Women with Urinary Incontinence. LEE, JAY H.; GOMEZ, SUZANNE; JANKOWSKI, TERRY ANN // American Family Physician;7/1/2011, Vol. 84 Issue 1, following p20 

    The article discusses whether hormone therapy improve urinary incontinence in postmenopausal women (PMW). The authors report that PMW should not receive oral hormone therapy for treatment of urinary incontinence. They say that in a 2009 Cochrane review of 33 trials including 19,313 women with...

  • Hormone therapy increased incidence and severity of urinary incontinence in healthy postmenopausal women: Commentary.. Atkins, David // Evidence Based Medicine;Aug2005, Vol. 10 Issue 4, p121 

    Discusses the role of hormone therapy in treating urinary incontinence (UI) among healthy postmenopausal women. Benefits of oestrogen on genital symptoms; Effects of oestrogen and progestin on UI; Recommendations on drug dosage for the treatment of the disease.

  • Urinary incontinence secondary to severe labial agglutination. Michael Flynn; Gunhilde Buchsbaum // International Urogynecology Journal;Feb2008, Vol. 19 Issue 2, p253 

    Abstract  The purpose of the study was to describe the presentation and management of urinary incontinence because of severe labial adhesions. Records of all patients diagnosed with labial agglutination and urinary incontinence at the Division of Gynecologic Specialties between...

  • Turner Syndrome: Transition from Pediatrics to Adulthood.  // Endocrine Practice;Sep2008, Vol. 14 Issue 6, p775 

    Objective: To highlight the importance of an improved, seamless, and effective transition from pediatric to adult care, especially for medically complex conditions such as Turner syndrome (TS).Methods: The morbidities in adult patients with TS are reviewed, including features of the metabolic...

  • Effects of Hormone Therapy on Urinary Incontinence. Walling, Anne D. // American Family Physician;12/15/2004, Vol. 70 Issue 12, p2369 

    Discusses research being done on the effects of hormone therapy on urinary incontinence. Reference to a study by F. Grodstein et al published in the February 2004 issue of "Obstetrics and Gynecology"; Number of women participating in the Nurses' Health Study; Age-adjusted relative risk of...

  • sex hormone.  // American Heritage Student Science Dictionary;2009, p308 

    A definition of the term "sex hormone" is presented. It refers to a steroid hormone that regulates the sexual development of an organism and is needed for reproduction. Testosterone and estrogen are sex hormones.

  • Menorest.  // Royal Society of Medicine: Medicines;2002, p352 

    The article presents information on Menorest which is a proprietary, prescription-only preparation of the estrogen estradiol. This drug can be used in osteoporosis prevention, and is available as skin patches in different strengths.

  • The estrogen receptor-a agonist 16a-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Pelzer, Theo; Jazbutyte, Virginija; Hu, Kai; Segerer, Stephan; Nahrendorf, Matthias; Nordbeck, Peter; Bonz, Andreas W.; Muck, Jenny; Fritzemeier, Karl-Heinrich; Hegele-Hartung, Christa; Ertl, Georg; Neyses, Ludwig // Cardiovascular Research;Sep2005, Vol. 67 Issue 4, p604 

    Abstract: Objective: Cardiac mass increases with age and with declining estradiol serum levels in postmenopausal women. Although the non-selective estrogen receptor-a and -� agonist 17�-estradiol attenuates cardiac hypertrophy in animal models and in observational studies, it remains...

  • Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: An ERa-mediated pathway. Geraldes, Pedro; Gagnon, St�phanie; Hadjadj, Sofiane; Merhi, Yahye; Sirois, Martin G.; Cloutier, Isabelle; Tanguay, Jean-Fran�ois // Cardiovascular Research;Aug2006, Vol. 71 Issue 3, p566 

    Abstract: Objective: Interferon gamma (IFN-?) was shown to induce CD40 and CD40L expression on endothelial cells (ECs) and consequently to promote neutrophil adhesion. The pro- and anti-inflammatory effects of estrogens are well recognized but their role on the regulation of CD40 and CD40L...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics